The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: A systematic review with meta-analysis

Cardiovascular Diabetology

Volumn 16, Issue 1, 2017, Pages

  Fuchs, Dagmar ^a   Dupon, Pepijn P ^a,b   Schaap, Laura A ^b   Draijer, Richard ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Laser Doppler flowmetry; Laser speckle contrast imaging; Microcirculation; Morphology; Skin perfusion; Vasodilation

Indexed keywords

BLOOD VESSEL REACTIVITY; DERMAL MICROVASCULAR DYSFUNCTION; DIABETES MELLITUS; DISEASE DURATION; HUMAN; IMAGING; INSULIN DEPENDENT DIABETES MELLITUS; LASER DOPPLER FLOWMETRY; LASER SPECKLE CONTRAST IMAGING; LOCAL THERMAL HYPEREMIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; QUADRICEPS FEMORIS MUSCLE; REVIEW; SKIN BLOOD FLOW; SKIN CAPILLARY; SYSTEMATIC REVIEW; THERMAL STIMULATION; DIABETES COMPLICATIONS; HEAT; HYPEREMIA; META ANALYSIS; MICROCIRCULATION; MICROVASCULATURE; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SKIN; VASCULARIZATION;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HOT TEMPERATURE; HUMANS; HYPEREMIA; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; MICROVESSELS; OBSERVATIONAL STUDIES AS TOPIC; SKIN;

EID: 85009909831     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0487-1     Document Type: Review

References (78)

1. Tryggestad JB, Willi SM. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications. 2015;29:307-12.
2. Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep. 2014;16:419.
3. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436-43.
4. Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol. 2012;10:19-32.
5. Tousoulis D, Kampoli AM, Papageorgiou N, Papaoikonomou S, Antoniades C, Stefanadis C. The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches. Curr Pharm Des. 2009;15:2037-48.
6. Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444-52.
7. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6:37-53.
8. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6:92-108.
9. Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42:747-87.
10. Morgan AJ, Schwartz RA. Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol. 2008;58:447-51.
11. Arya AK, Tripathi R, Kumar S, Tripathi K. Recent advances on the association of apoptosis in chronic non healing diabetic wound. World J Diabetes. 2014;5:756-62.
12. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856-62.
13. Thoresen M, Walloe L. Skin blood flow in humans as a function of environmental temperature measured by ultrasound. Acta Physiol Scand. 1980;109:333-41.
14. Vanggaard L, Kuklane K, Holmer I, Smolander J. Thermal responses to whole-body cooling in air with special reference to arteriovenous anastomoses in fingers. Clin Physiol Funct Imaging. 2012;32:463-9.
15. Berardesca E, Leveque JL, Masson P. EEMCO guidance for the measurement of skin microcirculation. Skin Pharmacol Appl Skin Physiol. 2002;15:442-56.
16. Briers JD. Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Meas. 2001;22:R35-66.
17. Mahe G, Humeau-Heurtier A, Durand S, Leftheriotis G, Abraham P. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging. 2012;5:155-63.
18. Oberg PA. Laser-Doppler flowmetry. Crit Rev Biomed Eng. 1990;18:125-63.
19. Fagrell B. Dynamics of skin microcirculation in humans. J Cardiovasc Pharmacol. 1985;7(Suppl 3):S53-8.
20. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci. 2006;27:503-8.
21. Walther G, Obert P, Fdr Dutheil, Chapier R, Lesourd B, Naughton G, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. Arterioscler Thromb Vasc Biol. 2015;35:1022-9.
22. Beer S, Fo Feihl, Ruiz J, In Juhan-Vague, Aillaud MF, Wetzel SG, et al. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag. 2008;4:1449-58.
23. Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation. 2012;19:47-64.
24. Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med. 2008;18:109-16.
25. Wright CI, Kroner CI, Draijer R. Non-invasive methods and stimuli for evaluating the skin's microcirculation. J Pharmacol Toxicol Methods. 2006;54:1-25.
26. Roustit M, Millet C, Blaise S, Dufournet B, Cracowski JL. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res. 2010;80:505-11.
27. Stevens MJ, Edmonds ME, Douglas SL, Watkins PJ. Influence of neuropathy on the microvascular response to local heating in the human diabetic foot. Clin Sci (Lond). 1991;80:249-56.
28. Eun HC. Evaluation of skin blood flow by laser Doppler flowmetry. Clin Dermatol. 1995;13:337-47.
29. Vongsavan N, Matthews B. Some aspects of the use of laser Doppler flow meters for recording tissue blood flow. Exp Physiol. 1993;78:1-14.
30. Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans. J Appl Physiol. 1985;2011(110):1406-13.
31. Minson CT. Thermal provocation to evaluate microvascular reactivity in human skin. J Appl Physiol. 2010;109:1239-46.
32. Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol. 2001;91:1619-26.
33. Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA. Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol. 2014;14:30.
34. Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to meta-analysis. New York: Wiley; 2009.
35. Cohen J. A power primer. Psychol Bull. 1992;112:155-9.
36. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
38. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, Version 5.1.0: The Cochrane Collaboration; 2011.
39. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769-73.
40. Abrams KR, Gillies CL, Lambert PC. Meta-analysis of heterogeneously reported trials assessing change from baseline. Stat Med. 2005;24:3823-44.
41. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-84.
42. Aellen J, Dabiri A, Heim A, Liaudet L, Burnier M, Ruiz J, et al. Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes. Microcirculation. 2012;19:554-62.
43. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia. 1995;38:1337-44.
44. Petrofsky J, Paluso D, Anderson D, Swan K, Alshammari F, Katrak V, et al. The ability of different areas of the skin to absorb heat from a locally applied heat source: the impact of diabetes. Diabetes Technol Ther. 2011;13:365-72.
45. Petrofsky JS, Alshammari F, Bains GS, Khowailed IA, Lee H, Kuderu YN, et al. What is more damaging to vascular endothelial function: diabetes, age, high BMI, or all of the above? Med Sci Monit. 2013;19:257-63.
46. Forst T, Caduff A, Talary M, Weder M, Brandle M, Kann P, et al. Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetes. Diabetes Technol Ther. 2006;8:94-101.
47. Skrha J, Prazny M, Haas T, Kvasnicka J, Kalvodova B. Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in type 1 diabetic patients. J Diabetes Complicat. 2001;15:234-40.
48. Rendell M, Bergman T, O'Donnell G, Drobny E, Borgos J, Bonner RF. Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes. 1989;38:819-24.
49. Brugler A, Thompson S, Turner S, Ngo B, Rendell M. Skin blood flow abnormalities in diabetic dermopathy. J Am Acad Dermatol. 2011;65:559-63.
50. Wigington G, Ngo B, Rendell M. Skin blood flow in diabetic dermopathy. Arch Dermatol. 2004;140:1248-50.
51. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, et al. Skin blood flow in necrobiosis lipoidica diabeticorum. Int J Dermatol. 2008;47:354-8.
52. Gomes MB, Matheus AS, Tibirica E. Evaluation of microvascular endothelial function in patients with type 1 diabetes using laser-Doppler perfusion monitoring: which method to choose? Microvasc Res. 2008;76:132-3.
53. Matheus AS, Tibirica E, da Silva PB, Matta dFBd, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med. 2011;28:1188-93.
54. Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care. 1998;21:1339-44.
55. Foster W, Carruthers D, Lip GY, Blann AD. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. J Rheumatol. 2010;37:711-6.
56. Doupis J, Rahangdale S, Gnardellis C, Pena SE, Malhotra A, Veves A. Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring). 2011;19:729-35.
57. Zomer E, de Ridder I, Kompa A, Komesaroff P, Gilbert R, Krum H. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension. Clin Exp Pharmacol Physiol. 2008;35:1147-50.
58. Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:740-7.
59. Caselli A, Hanane T, Jane B, Carter S, Khaodhiar L, Veves A. Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy. J Diabetes Complications. 2003;17:205-10.
60. Katz A, Ekberg K, Johansson BL, Wahren J. Diminished skin blood flow in type I diabetes: evidence for non-endothelium-dependent dysfunction. Clin Sci (Lond). 2001;101:59-64.
61. DiMeglio LA, Tosh A, Saha C, Estes M, Mund J, Mead LE, et al. Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J Pediatr. 2010;157:540-6.
62. Koitka A, Abraham P, Bouhanick B, Sigaudo-Roussel D, Demiot C, Saumet JL. Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes. Diabetes. 2004;53:721-5.
63. Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology. 2000;54:1246-52.
64. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 1999;22:1865-70.
65. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001;24:344-9.
66. Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, et al. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg. 2006;43:760-70.
67. Rousseau P, Mahe G, Fromy B, Ducluzeau PH, Saumet JL, Abraham P. Axon-reflex cutaneous vasodilatation is impaired in type 2 diabetic patients receiving chronic low-dose aspirin. Microvasc Res. 2009;78:218-23.
68. Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes Obes Metab. 2008;10:739-46.
69. Brooks BA, McLennan SV, Twigg SM, Yue DK. Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diab Vasc Dis Res. 2008;5:30-5.
70. Economides PA, Caselli A, Zuo CS, Sparks C, Khaodhiar L, Katsilambros N, et al. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism. 2004;53:222-7.
71. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035-87.
72. Charkoudian N. Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc. 2003;78:603-12.
73. Stirban A. Microvascular dysfunction in the context of diabetic neuropathy. Curr DiabRep. 2014;14:541.
74. Östlund Papadogeorgos N, Jörneskog G, Bengtsson M, Kahan T, Kalani M. Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome. Cardiovasc Diabetol. 2016;15:66.
75. Tomešová J, Gruberova J, Lacigova S, Cechurova D, Jankovec Z, Rusavy Z. Differences in skin microcirculation on the upper and lower extremities in patients with diabetes mellitus: relationship of diabetic neuropathy and skin microcirculation. Diabetes Technol Ther. 2013;15:968-75.
76. Taub PR, Higginbotham E, Henry RR. Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes. Curr Cardiol Rep. 2013;15:332.
77. Blonde L. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am J Med Sci. 2012;343:17-20.
78. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-12.